Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

416 results about "Sesquiterpene" patented technology

Sesquiterpenes are a class of terpenes that consist of three isoprene units and often have the molecular formula C₁₅H₂₄. Like monoterpenes, sesquiterpenes may be acyclic or contain rings, including many unique combinations. Biochemical modifications such as oxidation or rearrangement produce the related sesquiterpenoids.

Dimer compound of guaiane type sesquiterpenes and uric acid as well as extraction and separation method and application of dimer compound

The invention relates to the field of natural products, in particular to a dimer compound of guaiane type sesquiterpenes and uric acid as well as an extraction and separation method and application of the dimer compound. According to the invention, a new dimer compound of guaiane type sesquiterpene and uric acid is extracted and separated from carpesium abrotanoides in Guizhou, and it is found that the dimer compound has relatively strong anti-tumor activity. The compound has strong inhibitory activity on breast cancer, prostate cancer, nasopharynx cancer, liver cancer, lung cancer, leukemia, pancreatic cancer, glioma, osteosarcoma, skin cancer, cervical cancer, ovarian cancer, kidney cancer and esophageal cancer, and provides an optional scheme for broad-spectrum anti-cancer drugs. Moreover, in human prostate cancer cells PC3, human cervical cancer cells Hela, human liver cancer cells HepG2 and human glioma cells U87 which are resistant to paclitaxel, the compound also shows strong anti-cancer activity, which indicates that the compound has the potential of treating patients resistant to paclitaxel.
Owner:KUNMING MEDICAL UNIVERSITY +1

Sesquiterpenoids as well as preparation method and application thereof

The invention discloses sesquiterpenoids as well as a preparation method and application thereof. The structure of the sesquiterpenoids is shown in the specification. The sesquiterpenoids of # imgabs0 can be used for preparing drugs for preventing and / or treating cancers, and the cancers comprise at least one of breast cancer, liver cancer, lung cancer, colorectal cancer, leukemia, pancreatic cancer, glioma, osteosarcoma, cervical cancer, kidney cancer and skin cancer. According to the invention, various natural product extracts are subjected to activity screening, the sesquiterpenoids derived from the rattan chrysanthemum have excellent inhibitory activity on various different types of human cancer cells, and an optional scheme is provided for broad-spectrum anti-cancer drugs. The sesquiterpenoids applied in the invention are derived from rattan chrysanthemum, the source is wide, and the production cost is low.
Owner:GUIZHOU MEDICAL UNIV +1

Application of sesquiterpenoids in preparation of medicine for treating or preventing infectious diseases caused by staphylococcus aureus

The invention belongs to the technical field of medicines, and particularly relates to application of sesquiterpenoids and / or pharmaceutically acceptable salts thereof in preparation of medicines for treating or preventing infectious diseases caused by staphylococcus aureus. The invention relates to the field of medicines, in particular to application in preparation of medicines for treating or preventing infectious diseases caused by drug-sensitive staphylococcus aureus or drug-resistant staphylococcus aureus. The structure of the sesquiterpenoids is shown as a formula I in the specification. The sesquiterpenoids applied in the invention are derived from rattan chrysanthemum, the source is wide, and the production cost is low. The sesquiterpenoids shown in the formula I have a very good activity inhibition effect on staphylococcus aureus for the first time, and the sesquiterpenoids have a very good activity inhibition effect on staphylococcus aureus with drug sensitivity, drug medium or drug resistance.
Owner:KUNMING MEDICAL UNIVERSITY

Sesquiterpene dimer in artemisia selengensis, pharmaceutical composition of sesquiterpene dimer, preparation method of sesquiterpene dimer and application of sesquiterpene dimer

PendingCN120040466AOrganic active ingredientsOrganic chemistryDimerArtemisia selengensis
The invention provides a sesquiterpene dimer in artemisia selengensis, a pharmaceutical composition of the sesquiterpene dimer and a preparation method and application of the sesquiterpene dimer, and belongs to the technical field of medicines. According to the present invention, the eight new sesquiterpene dimers represented by the structural formula of the present invention, artemselenoids A-H (1-8) have significant inhibitory activity on three liver cancer cells (HepG2, Huh7 and SK-Hep-1), can form the pharmaceutical composition with the pharmaceutically acceptable carrier, and can be used for preparing the anti-liver cancer drug.
Owner:KUNMING INST OF BOTANY CHINESE ACAD OF SCI

PzGGPS12 gene of phoebe zhennan and application of PzGGPS12 gene in improvement of yield and drought tolerance of plant terpenoids

PendingCN120555471ATransferasesFermentationBiotechnologyPhoebe nanmu
The invention discloses a phoebe zhennan PzGGPS12 gene and application of the phoebe zhennan PzGGPS12 gene to improvement of yield and drought tolerance of plant terpenoids, and belongs to the field of genetic engineering, a key enzyme gene PzGGPS12 for catalyzing biosynthesis of the terpenoids in phoebe zhennan wood is screened and analyzed, and a full-length CDS nucleic acid sequence of the PzGGPS12 is obtained. Transgenic experiments prove that overexpression of the gene improves the relative content of tobacco monoterpenes and triterpenes. Short-term drought experiments prove that overexpression of the gene can promote biosynthesis of sesquiterpenes, diterpenes and triterpenes so as to enhance drought tolerance of transgenic tobacco. Therefore, the gene can be introduced into a plant as a target gene, the yield of terpenoids in the plant is increased, and the drought tolerance of the plant is enhanced so as to improve the variety of the plant.
Owner:SICHUAN FORESTRY RES INST (SICHUAN FORESTRY IND RES & DESIGN INST) +2

Marine streptomyces strain SHEa3, compound derived from marine streptomyces strain and application of marine streptomyces strain SHEa3

The invention discloses a marine streptomyces strain SHEa3, a compound derived from the marine streptomyces strain SHEa3 and application of the marine streptomyces strain SHEa3, the classification name of the marine streptomyces strain SHEa3 is Streptomyces sp, the preservation number of the marine streptomyces strain SHEa3 is GDMCC No: 66667, and the preservation date of the marine streptomyces strain SHEa3 is July 14, 2025. The invention also discloses a sesquiterpenoids compound streptaviol A derived from marine streptomyces and application of the sesquiterpenoids compound streptaviol A in preparation of drugs for preventing and treating vibrio diseases of mariculture animals. The invention further discloses application of the sesquiterpenoids, namely the sea threitol C, derived from the marine streptomyces in preparation of drugs for preventing and treating vibrio diseases of mariculture animals. The marine streptomyces source compound has efficient anti-vibrio activity, and the marine streptomyces source compound streptaviol A and the helithreitol C are used for preparing the medicine for preventing and treating vibrio diseases of mariculture animals, so that the side effect is low, and the activity is excellent.
Owner:HAINAN ACADEMY OF OCEAN & FISHERIES SCI +1

Sesterterpenoids, preparation method thereof and application of sesterterpenoids in preparation of medicine for treating psoriasis

The invention discloses a sesterterpenoid compound, a preparation method thereof and application of the sesterterpenoid compound in preparation of a medicine for treating psoriasis, and belongs to the technical field of biological medicine. Comprising a compound 1-4, and the structural formula of the compound 1-4 is as follows: # imgabs0. A new molecular template is provided for developing a new psoriasis treatment medicine, and a new thought is provided for further developing a novel treatment strategy with an immunomodulatory effect.
Owner:HUAZHONG UNIV OF SCI & TECH

Aroma compounds

PCT designated stage expiredWO2025109088A2OxidoreductasesSesquiterpeneCytochrome P450 Family
The present invention relates to processes for the oxidation of sesquiterpenes comprising fused 5- and 7-membered rings using mutant Cytochrome P450 family 102A sub-family member (CYP102A) enzymes. The invention also relates to mutant CYP102A enzymes, polynucleotides encoding the enzymes, cells expressing the enzymes, transgenic animals or plants comprising the enzymes, and compounds produced by the processes.
Owner:OXFORD UNIVERSITY INNOVATION LTD

Inula flower extract, preparation method thereof and cosmetic composition

The invention relates to the technical field of cosmetics, in particular to an inula flower extract, a preparation method thereof and a cosmetic composition. The invention relates to an inula flower extract for reducing skin texture (smoothing skin), resisting wrinkles, enriching apple muscle, lifting mandibular line, reducing pore depth and improving skin elasticity, the extract comprises an aqueous extract of inula flower and / or an organic solvent extract, and the volume fraction of the organic solvent is 0.01%-100%. The inula flower extract disclosed by the invention is rich in phenolic acid, flavone, polysaccharide and sesquiterpenoids, and has the effects of reducing the skin texture degree (smoothing the skin), resisting wrinkles, enriching apple muscles, lifting the mandibular line, reducing the pore depth and improving the skin elasticity.
Owner:BEIJING ACAD OF TCM BEAUTY SUPPLEMENTS CO LTD

Microbial chassis cell capable of producing terpenoids at high yield and application of microbial chassis cell

The invention discloses a microbial chassis cell capable of producing terpenoids at high yield and application of the microbial chassis cell. Based on gene homologous recombination of a specific site mediated by a conjugational transfer technology, a key rate-limiting enzyme gene of an MEP pathway is overexpressed in an integrated manner at a gene high expression site in a genome, streptomyces chassis cells with high yield of terpenes are established, and establishment of an efficient production system of sesquiterpenes and diterpenes is realized. By utilizing the microorganism provided by the embodiment of the invention, the yields of bisabolol, 18-carboxyl labdate, kaurene and atelonic acid are obviously improved, the production period is short, and the production efficiency is high.
Owner:CHINA PHARM UNIV

Saccharomyces cerevisiae recombinant strain based on uracil metabolism gene URA3 as well as construction method and application of saccharomyces cerevisiae recombinant strain

PendingCN120866093AFungiMicroorganism based processesBiosynthetic genesUracil metabolism
The invention discloses a saccharomyces cerevisiae recombinant strain based on a uracil metabolism gene URA3 as well as a construction method and application of the saccharomyces cerevisiae recombinant strain. The construction method comprises the following steps: taking saccharomyces cerevisiae rich in farnesyl pyrophosphate as an original strain, introducing a uracil metabolism gene URA3, synchronously overexpressing a ribosome biosynthetic gene UTP10 and an iron metabolism gene FIT3, and utilizing the uracil metabolism gene URA3 to express up-regulation correlation with the ribosome biosynthetic gene UTP10 and the iron metabolism gene FIT3, so as to obtain the farnesyl pyrophosphate-rich saccharomyces cerevisiae. The metabolic flux of the terpenoids is enhanced, and the saccharomyces cerevisiae recombinant strain for efficiently producing the terpenoids is constructed. According to the method, a metabolic network of yeast is systematically optimized, and combined regulation and control on precursor flux distribution, protein translation capability and metal ion steady state are realized, so that the microbial synthesis efficiency of sesquiterpenoids such as patchouli alcohol and beta-elemene is remarkably improved.
Owner:EAST CHINA UNIV OF SCI & TECH

Efficient production of novel rimane type sesquiterpene compound by using SsDMS mutant

The invention discloses a directed evolution strategy of type II sesquiterpene cyclase (SsDMS) derived from Streptomyces shedoensis based on alanine scanning, and an application of the type II sesquiterpene cyclase (SsDMS) derived from Streptomyces shedoensis based on alanine scanning. The invention relates to a plurality of SsDMS key mutant sites capable of catalytically generating a novel drive type sesquiterpenoid compound, which comprise substitution of sites 208, 248, 249, 497 and 505, and the SsDMS key mutant sites comprise substitution of sites 208, 248, 249, 497 and 505. The invention discloses an efficient escherichia coli cell factory applied to heterologous expression of an SsDMS mutant and efficient production of a novel drive type sesquiterpene compound, and further obtains the drive type sesquiterpene compound with a novel structure. According to the present invention, the efficient production of the drive type sesquiterpene compound by using the SsDMS and the mutant thereof is achieved, the modification strategy has wide applicability, the important enzymology resource is provided for the biosynthesis of the novel terpene compound, and the more choices are provided for the discovery of the drug lead compound.
Owner:CHINA PHARM UNIV

Extraction method and application of aza sesquiterpenoids

The invention discloses an extraction method and application of an aza-sesquiterpenoid compound which is derived from marine fungi and has anti-prostatic cancer activity. The structure of the aza-sesquiterpenoid compound is shown as a formula I-3 or pharmaceutical salt of the aza-sesquiterpenoid compound: # imgabs0 #, wherein the compound 1 is pyripyropene E, the compound 2 is pyripyropene O, and the compound 3 is 11-deacetylated pyripyropene A (11-deacetylated PPPA). The invention further discloses a preparation method of the aza-sesquiterpenoid compound with the anti-prostatic cancer activity and application of the aza-sesquiterpenoid compound with the anti-prostatic cancer activity and application of the aza-sesquiterpenoid compound with the anti-prostatic cancer activity. Molecular docking analysis shows that the compound shows anti-prostatic cancer activity, further experiments find that the compound pyripyroene O (compound 2) has remarkable cytotoxic activity on prostatic cancer cells, an alternative compound is provided for developing new prostatic cancer treatment, and the compound 2 has important significance on development of marine drug resources in China.
Owner:SOUTH CHINA SEA INST OF OCEANOLOGY CHINESE ACAD OF SCI

Saccharomyces cerevisiae engineering strain for producing caryophyllene and application thereof

The invention relates to the technical field of bioengineering, in particular to a saccharomyces cerevisiae engineering strain for producing caryophyllene and application of the saccharomyces cerevisiae engineering strain. The invention provides a saccharomyces cerevisiae engineering strain which has enhanced expression and / or activity of mevalonic acid pathway enzyme and one or more modifications selected from the following (1)-(2): (1) weakened expression and / or activity of sterol synthesis pathway enzyme; (2) attenuated expression and / or activity of fatty acid synthetic pathway enzymes; compared with an original strain, the saccharomyces cerevisiae engineering strain has the advantage that the sesquiterpene yield is increased. Compared with an original strain, the saccharomyces cerevisiae engineering strain has the advantages that the production capacity of the sesquiterpenes such as the caryophyllene is obviously improved, the sesquiterpenes such as the caryophyllene can be efficiently synthesized, and the saccharomyces cerevisiae engineering strain has better application value.
Owner:CHINA PETROLEUM & CHEMICAL CORP +2

Cadinane type sesquiterpene as well as preparation method and application thereof

The invention discloses a cadinane type sesquiterpene as well as a preparation method and application thereof. The cadinane type sesquiterpene is separated from cinnamon bark, and has at least one of structural formulas shown as a formula (I), a formula (II), a formula (III) and a formula (IV). Liver protection activity evaluation is carried out by applying an alcohol-induced hepatocyte injury model, and it is found that the cadinane type sesquiterpene can effectively relieve alcohol-induced AML-12 hepatocyte injury; the dumarane sesquiterpenes can inhibit the alcoholic liver disease and relieve fat accumulation, so that the dumarane sesquiterpenes have the anti-alcoholic liver disease activity, can be applied to preparation of the anti-alcoholic liver disease drugs, and have good research and development prospects; belongs to the field of natural medicinal chemistry.
Owner:GUANGDONG UNIV OF TECH

Function and application of transcription factor NAC42

The invention provides a function and application of a transcription factor NAC42. The invention discloses a novel gene NAC42 which is closely related to regulation and control of phytoalexin, volatile monoterpenes and sesquiterpenes of plants (so as to regulate and control insect resistance). The invention provides a new way for improving the insect resistance of plants.
Owner:CAS CENT FOR EXCELLENCE IN MOLECULAR PLANT SCI +1

Application of artemisia rupestris extract in preparation of medicine for preventing and treating lung diseases

The invention relates to application of an Artemisia rupestris extract in preparation of medicines for preventing and treating lung diseases. According to the application of the artemisia rupestris extract in preparation of the medicine for preventing and treating the lung diseases, the artemisia rupestris extract is prepared by taking artemisia rupestris as a raw material, and the crude drug concentration is 20-110 mg / mL. The artemisia rupestris extract contains chemical components such as sesquiterpenoids, flavonoids, organic acids and phenylpropanoids. The medicine is a veterinary medicine. The lung diseases comprise allergic pneumonia, pulmonary fibrosis or diseases caused by injury of other lung tissues. The dosage form of the medicine for preventing and treating the lung diseases is a pharmaceutically acceptable dosage form. The pharmaceutically acceptable dosage form is oral liquid, powder, tablets, granules, capsules, pills, syrup, suspension or emulsion. The application defines the prevention and treatment effect of the Artemisia rupestris extract on lung diseases. During application, the artemisia rupestris extract is small in dosage and high in curative effect, and the weight of livestock and poultry can be greatly reduced due to the fact that lung tissue is damaged.
Owner:CHINA AGRI UNIV

Biosynthetic gene cluster of novel skeleton sesquiterpenes terrecyclic acid and application of biosynthetic gene cluster

PendingCN120400194AHydrolasesMicroorganism based processesSesquiterpenoid biosynthesisBiosynthetic genes
The invention discloses a biosynthetic gene cluster of a novel skeleton sesquiterpenoid (sestercyclic acid) and an application of the biosynthetic gene cluster of the novel skeleton sestercyclic acid (sestercyclic acid). The sesterterpene tercyclic acid biosynthetic gene cluster at least comprises three genes, namely, terA, terB and terC, and the nucleotide sequences of the sesterterpene tercyclic acid biosynthetic gene cluster are as shown in SEQ ID NO.1-3. The gene cluster of the terrecyclic acid compound disclosed by the invention is found for the first time, and each gene function is also confirmed for the first time. Protease TerA catalyzes farnesyl pyrophosphate (FPP) to be cyclized into a new skeleton sesquiterpene 25, then P450 protease TerB is oxidized into a compound 32, and the compound 32 is dehydrogenated through protease TerC to form a final product compound 2. According to the present invention, the effective drug source approach is provided for the development of the terrecyclic acid antitumor compound.
Owner:SOUTH CHINA SEA INST OF OCEANOLOGY CHINESE ACAD OF SCI

A neurospora crassa and applications thereof

The application belongs to the technical field of microorganisms and particularly relates to a kind of Aspergillus ustus and application thereof.The Aspergillus ustus is preserved in China General Microbiological Culture Collection Center, and the preservation number is CGMCC No.40820.The Aspergillus ustus can be separated to obtain sesquiterpenes shown in formula I and formula II, and the sesquiterpenes have good bacteriostatic activity on Physarum polycephalum, and the bacteriostatic rates are 79.45% and 76.71% respectively at a final concentration of 100 μg / mL, which is equivalent to the control agent of bercyn in inhibiting mycelial growth.
Owner:SHENYANG AGRI UNIV

Norsesquiterpenoids as well as preparation method and application thereof

The invention belongs to the field of natural medicines, and relates to a norsesquiterpenoids compound mycehainanic acid which is derived from branches and leaves of Adenocalyx hainanensis of a rubiaceae Adenocalyx plant and has a novel chemical structure, a preparation method of the norsesquiterpenoids compound, and application of the norsesquiterpenoids compound mycehainanic acid in antitumor medicines. Various in-vitro activity evaluation results of the compound mycehainanic acid show that the compound has remarkable anti-tumor activity and protein tyrosine kinase inhibition activity equivalent to that of a positive control drug, and can be further developed into an anti-tumor drug taking protein tyrosine kinase as a target, so that the medicinal value and the economic value of the compound are fully exerted; and the separation and purification process is simple and has practical significance.
Owner:HAINAN NORMAL UNIV

A method for genetic transformation and gene editing applicable to multiple species of achenes

This invention discloses a genetic transformation and gene editing method applicable to multiple sesquiterpene species, belonging to the field of plant genetic transformation and gene editing technology. The method uses the cotyledonary nodes of sterile seedlings of the sesquiterpene genus as explants, and introduces an optimized pScEF1α-Cas9 gene editing transformation vector using Agrobacterium infection. Regenerated plants are obtained through recovery culture, selection culture, and rooting culture. The vector contains four gene expression units: pScEF1α:Cas9, pGmU6:sgRNA, pGmUBI:DsRed2, and pCaMV35S:HygR. In vivo screening is further performed using the DsRed2 fluorescent reporter gene, and the gene-edited plants are identified by molecular detection. This method is applicable to common sesquiterpene, stem-nodled sesquiterpene, and spiny sesquiterpene, and has advantages such as strong species versatility, high transformation efficiency, short cycle, visualized screening, and high positive rate, providing efficient technical support for gene function research and genetic improvement of sesquiterpene species.
Owner:INST OF GENETICS & DEVELOPMENTAL BIOLOGY CHINESE ACAD OF SCI

Curcuma wenyujin sesquiterpene synthase CwTPS8 as well as coding gene and application thereof

The invention discloses curcuma wenyujin sesquiterpene synthase CwTPS8 as well as a coding gene and application thereof, and belongs to the technical field of plant genetic engineering, the amino acid sequence of the curcuma wenyujin sesquiterpene synthase CwTPS8 is shown as SEQ ID NO.1, the nucleotide sequence of the gene for coding the curcuma wenyujin sesquiterpene synthase CwTPS8 is shown as SEQ ID NO.2, and the nucleotide sequence of the gene for coding the curcuma wenyujin sesquiterpene synthase CwTPS8 is shown as SEQ ID NO.1. The curcuma wenyujin sesquiterpene synthase CwTPS8 can be used for preparing beta-caryophyllene, alpha-humulene and other curcuma wenyujin sesquiterpenoids by taking farnesyl pyrophosphate FPP as a substrate, and the technology can be used for subsequently producing the sesquiterpenoids through a microbial cell factory. Meanwhile, a foundation is laid for heterologous synthesis and further development and utilization of sesquiterpenoids such as beta-caryophyllene and alpha-humulene.
Owner:HANGZHOU NORMAL UNIVERSITY

Use of sesquiterpenes in the preparation of a medicament for preventing and / or treating pulmonary fibrosis

The application relates to application of a sesquiterpenoid compound in preparation of a medicine for preventing and / or treating pulmonary fibrosis. The sesquiterpenoid compound has obvious inhibiting collagen deposition effect on TGF-beta 1 induced human embryo lung fibroblasts, does not show cytotoxicity, has good anti-pulmonary fibrosis activity, and can be used for preparing the medicine for preventing and / or treating pulmonary fibrosis.
Owner:SHENZHEN ZHONGXIN LIFE TECH CO LTD

Recombinant genetically engineered bacterium for synthesizing terpenoids as well as preparation method and application of recombinant genetically engineered bacterium

The invention relates to a recombinant genetically engineered bacterium for synthesizing terpenoids. The recombinant genetically engineered bacterium is saccharomyces cerevisiae in which a gal80 gene, an lpp1 gene and a dpp1 gene are knocked out and a heterologous MVA pathway gene and an AuoblA gene are integrated. According to the invention, a ophiobollin synthesis route is introduced into the saccharomyces cerevisiae in a heterologous manner for the first time, so that de novo synthesis of a ophiobollin skeleton compound, namely the ophiobollin F and an oxidation product of the ophiobollin F is realized; the synthesis of the ophiobolin F of 5.1 g / L is realized, which is also the highest sesterterpene heterologous synthesis yield reported at present; according to the invention, the ophiobolin 5-OH-21-CHO-opF with a new structure, which has excellent anti-cancer activity, is obtained through identification; the engineering strain of high-yield ophiobolin U is constructed, and the shake flask yield reaches 128.9 mg / L.
Owner:WUHAN JIAHAI ZHIYAO TECHNOLOGY CO LTD

Synthesis and use of novel drimane sesquiterpenoids of khamkhaine type from thai basidiomycota

The present invention refers to a method for the preparation of a compound according to formula (45), its enantiomers, diastereomers, a racemic mixture, and the pharmaceutically acceptable salts thereof. Furthermore the invention refers to a compound of formula (45) prepared by said method for use in treatment of neurodegenerative disorders and to pharmaceutical compositions.
Owner:OTTO VON GUERICKE UNIV MAGDEBURG KORPERSCHAFT DES OFFENTLICHEN RECHTS

Terpenoids Derived from Fungi, Their Preparation Methods and Applications

The present invention discloses terpene compounds derived from polar fungi, their preparation methods and applications, and respectively provides a calamenane-type sesquiterpene compound eutyacorane and a pimarane-type diterpene compound libertellenone Z derived from polar fungi. The structures are shown in the following formulas I and II respectively: The experimental results show that the two compounds have a better inhibition rate on the release of NO in the LPS-induced inflammatory model of mouse macrophages RAW264.7, providing a new type of choice for anti-inflammatory drugs.
Owner:THE NAVAL MEDICAL UNIV OF PLA

Dihydro-beta-agilawood furan type sesquiterpenoids as well as preparation method and application thereof

The invention discloses a dihydro-beta-agilawood furan type sesquiterpenoids compound as shown in a formula (I) as well as a preparation method and application thereof. The compound provided by the invention can promote cartilage cell proliferation and reverse mRNA expression of symbolic genes Col2A1 and SOX-9 in cartilage cells under inflammation induction; meanwhile, the expression of inflammation-induced cartilage cell matrix metalloproteinase-13mRNA can be down-regulated, the degradation of cartilage cell extracellular matrix can be inhibited, and the cartilage cell metalloproteinase-13mRNA can be used for preparing products for preventing and / or treating diseases or symptoms caused by abnormal cartilage cell activity and / or improving bone and joint movement functions. # imgabs0 #
Owner:上海市伤骨科研究所 +1

Use of a sesquiterpene synthase and mutants thereof in the synthesis of drimane compounds

PendingCN122445617AEscherichia coliHeterologous
The application belongs to the field of enzyme genetic engineering, and particularly relates to application of a sesquiterpene synthase and a mutant thereof in synthesis of enantiomeric-drimenol compounds, wherein the sesquiterpene synthase is a sesquiterpene synthase from Chenopodium quinoa Willd., and includes CqDMDS1 or CqDMDS2; the mutant of the sesquiterpene synthase is a mutant CqDMDS1 in which an amino acid at position 443 of CqDMDS1 is mutated F443A / G The application realizes heterologous expression of the sesquiterpene synthase and the mutant thereof from Chenopodium quinoa Willd. in an Escherichia coli and a N. benthamiana expression system, catalyzes synthesis of (-)‑8,11-driman-diol or (+)‑drimenol. It is found through activity test that the sesquiterpene synthase from Chenopodium quinoa Willd. has a significant inhibitory effect on plant pathogenic fungi Phytophthora nicotianae, Phytophthora sojae and Fusarium graminearum. The sesquiterpene synthase and the mutant thereof and the biological preparation of the catalytic product have important significance for development of biological pesticides.
Owner:SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Method for increasing content of sesquiterpene glycoside in dendrobium nobile

The invention belongs to the technical field of medicinal plant cultivation, and particularly provides a method for increasing the content of sesquiterpene glycoside in dendrobium nobile. The method comprises the step of applying a magnesium ion-containing solution with effective concentration at the growth stage of dendrobium nobile. Preferably, the magnesium ion-containing solution is a magnesium chloride solution, the application concentration is 10-500 mg / L, the magnesium ion-containing solution is applied in a foliage spraying or root irrigation mode, and the key period of application is the rapid growth period or the effective component accumulation period of the dendrobium nobile. The promotion effect of exogenous magnesium ions on biosynthesis of the sesquiterpene glycoside of the dendrobium nobile is disclosed for the first time, and the content of sesquiterpene glycoside components in the dendrobium nobile medicinal material can be remarkably increased under the condition that a basic cultivation mode is not changed, so that the medicinal potential and market value of immunoregulation, anti-inflammation and the like of the dendrobium nobile medicinal material are enhanced. The method is simple, efficient, low in cost, free of pollution and suitable for industrial application.
Owner:ZUNYI MEDICAL UNIVERSITY